Control of experimental and clinical burn wounds sepsis by topical application of sulfamylon compounds.
D000818:Animals; D002056:Burns / Q000188:drug therapy* / Q000382:microbiology* / Q000401:mortality; D006801:Humans; D008722:Methods; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D051381:Rats; D018805:Sepsis; D013210:Staphylococcus / Q000302:isolation & purification; D013449:Sulfonamides / Q000627:therapeutic use*; D014774:Virulence
D013449:Sulfonamides